CHARLES K SONALIYA
Allopathic & Osteopathic Physicians|Internal Medicine MILLVILLE, NJ NPI 1124606926
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine NJ PFIZER INC. All categories
General Payments — all program years on this page
$135.47
- Category: General Payments
- Program years: PY2024
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $135.47 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $135.47 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $51.01 | 3 |
| Axsome Therapeutics, Inc. | $18.98 | 1 |
| Amgen Inc. | $18.96 | 1 |
| Acerta Pharma LLC | $16.65 | 1 |
| Kowa Pharmaceuticals America, Inc. | $16.32 | 1 |
| ABBVIE INC. | $13.55 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $135.47 | 8 |
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1104303170 | AstraZeneca Pharmaceuticals LP | $16.65 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1106137703 | ABBVIE INC. | $13.55 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111713164 | Amgen Inc. | $18.96 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1113470707 | Kowa Pharmaceuticals America, Inc. | $16.32 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131543788 | PFIZER INC. | $14.31 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131569950 | PFIZER INC. | $18.68 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131609822 | PFIZER INC. | $18.02 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148271399 | Axsome Therapeutics, Inc. | $18.98 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.